Understanding PRJD1: A Potential Drug Target and Regulator of Cellular Processes

Target Name: PRR35

NCBI ID: G146325

PRR35

Understanding PRJD1: A Potential Drug Target and Regulator of Cellular Processes

Protein RJD1 (PRR35) is a highly conserved protein that is expressed in various cell types of the human body. It is a member of the superfamily of F-type cytoskeletal proteins, which are involved in the regulation of cell shape and movement. PRJD1 is unique due to its unique sequence and structural features. The protein is highly expressed in the brain, and its presence has been linked to various neurological disorders. Despite its unique features, PRJD1 has not yet been studied extensively, and its functions are not well understood.

The protein encoded by the PRJD1 gene is a 194 amino acid long protein that has a molecular weight of 21.9 kDa. PRJD1 is expressed in various cell types of the human body, including neurons, astrocytes, and glial cells. The protein is highly conserved, with a calculated pI of 6.5 and a predicted localization in the cytoplasm.

PRJD1 is involved in the regulation of various cellular processes, including cell adhesion, migration, and the regulation of the cytoskeleton. It plays a critical role in the regulation of neuronal excitability and synaptic plasticity. The protein is involved in the regulation of ion channels, including the Na+/K+-ATPase, which is responsible for maintaining the resting membrane potential of the neuron.

PRJD1 has also been shown to be involved in the regulation of cell death. The protein has been shown to be involved in the regulation of apoptosis, which is a critical mechanism of cell death that helps to remove damaged or dysfunctional cells from the body.

In addition to its involvement in cellular processes, PRJD1 has also been shown to be a potential drug target. The protein is known to interact with various drug molecules, including GABA, a neurotransmitter that has been shown to have neuroprotective properties. The interaction between PRJD1 and GABA has been shown to play a role in the regulation of neuronal excitability and the treatment of various neurological disorders.

PRJD1 has also been shown to be involved in the regulation of inflammation. The protein has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1. This involvement in inflammation has important implications for the development of inflammatory disorders.

Conclusion
In conclusion, PRJD1 is a unique and conserved protein that is involved in various cellular processes in the human body. Its functions are not well understood, and its potential as a drug target or biomarker is an exciting area of research. Further studies are needed to fully understand the role of PRJD1 in cellular processes and its potential as a drug target.

Protein Name: Proline Rich 35

The "PRR35 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRR35 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets